Breast cancer drug study halted after two deaths
Key points
- A test using two chemotherapy agents to treat breast cancer was halted after two women in the study died, French researchers reported on Tuesday.
- The test involved a combination of doxorubicin and docetaxel and followed a line of research that has shown combinations of certain breast cancer drug types are better that one kind alone to combat advanced and spreading breast cancer, the report said.
- "In conclusion, this study shows that the doxorubicin-docetaxel combination is associated with an increased risk of severe ... and life-threatening complications," said the study appearing in this week's Journal of the American Medical Association.
- Researchers should be aware of the potential toxicity of the combination, added the study.
A test using two chemotherapy agents to treat breast cancer was halted after two women in the study died, French researchers reported on Tuesday.
The test involved a combination of doxorubicin and docetaxel and followed a line of research that has shown combinations of certain breast cancer drug types are better that one kind alone to combat advanced and spreading breast cancer, the report said.
"In conclusion, this study shows that the doxorubicin-docetaxel combination is associated with an increased risk of severe ... and life-threatening complications," said the study appearing in this week's Journal of the American Medical Association.
Researchers should be aware of the potential toxicity of the combination, added the study.
The research was done by the Huguenin Cancer Center, Saint-Cloud, France and involved 627 women ages 18 to 70. The aim was to extend their survival for at least five years.
It began in 1999 and was halted in January 2003, following two deaths related to drug poisoning as well as one case of peritonitis, an inflammation of the membrane of the abdomen.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsAutophagy-addicted breast cancers killed by anti-malaria drug, chloroquine
The process of autophagy cleans cells – they wrap up the bad stuff and then dispose of it. And so it stands to reason that inhibiting autophagy would make cancer cells less able to cleanse themselves of chemotherapy and…
9 April 2013
NewsIn breast cancer metastasis, researchers identify possible drug target
The spread of breast cancer to distant organs within the body, an event that often leads to death, appears in many cases to involve the loss of a key protein, according to UC San Francisco researchers, whose new…
28 January 2013
NewsLSUHSC research provides new drug target for Her-2 related breast cancer
Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, details exactly how the Her2 cancer…
23 January 2013
